Web Exclusives
New Issue Alert: April 2019
BY BRIELLE BENYON
FDA Approves Pembrolizumab/Axitinib Combo for Frontline RCC
BY GINA COLUMBUS
Special Concerns in Treating LGBTQ Patients With Cancer
BY BRIELLE BENYON
FDA Approves Erdafitinib for Advanced Bladder Cancer
BY BRIELLE BENYON
FDA Expands Pembrolizumab Approval for Lung Cancer
BY GINA COLUMBUS
Patient-Nurse Communication Aids in Educating on Neuroendocrine Tumors
BY KRISTIE L. KAHL
FDA Expands Palbociclib Approval for Male Breast Cancer
BY BRIELLE BENYON
Pembrolizumab Is Promising in Small Cell Lung Cancer
BY KRISTI ROSA
Nurse Discusses How to Improve Compliance for Genetic Screening
BY BRIELLE BENYON
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.